Walleye Capital LLC Adamas Pharmaceuticals, Inc. Call Options Transaction History
Walleye Capital LLC
- $46.2 Billion
- Q3 2024
About Adamas Pharmaceuticals, Inc.
- Ticker ADMS
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,408,100
- Market Cap $376M